275 related articles for article (PubMed ID: 32813226)
21. ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin.
Agaimy A; Erlenbach-Wünsch K; Konukiewitz B; Schmitt AM; Rieker RJ; Vieth M; Kiesewetter F; Hartmann A; Zamboni G; Perren A; Klöppel G
Mod Pathol; 2013 Jul; 26(7):995-1003. PubMed ID: 23503646
[TBL] [Abstract][Full Text] [Related]
22. INSM1 Expression in Breast Neoplasms with Neuroedocrine Features.
Metovic J; Castellano I; Marinelli E; Osella-Abate S; Sapino A; Cassoni P; Papotti M
Endocr Pathol; 2021 Dec; 32(4):452-460. PubMed ID: 34008122
[TBL] [Abstract][Full Text] [Related]
23. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
Doxtader EE; Mukhopadhyay S
Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
[TBL] [Abstract][Full Text] [Related]
24. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.
Roy M; Buehler DG; Zhang R; Schwalbe ML; Baus RM; Salamat MS; Lloyd RV; Rosenbaum JN
Endocr Pathol; 2019 Mar; 30(1):35-42. PubMed ID: 30523500
[TBL] [Abstract][Full Text] [Related]
25. Insulinoma-associated Protein 1 Expression and Its Diagnostic Significance in Female Genital Tract Neuroendocrine Carcinomas.
Ting CH; Wang TY; Wu PS
Int J Gynecol Pathol; 2021 Sep; 40(5):452-459. PubMed ID: 33323849
[TBL] [Abstract][Full Text] [Related]
26. Expression of insulinoma-associated protein 1 in non-small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors.
Wang M; Abi-Raad R; Baldassarri R; Adeniran AJ; Cai G
Hum Pathol; 2021 Sep; 115():104-111. PubMed ID: 34216697
[TBL] [Abstract][Full Text] [Related]
27. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
[TBL] [Abstract][Full Text] [Related]
28. Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features.
Turkevi-Nagy S; Báthori Á; Böcz J; Krenács L; Cserni G; Kővári B
Pathol Oncol Res; 2021; 27():1610039. PubMed ID: 34764822
[No Abstract] [Full Text] [Related]
29. Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract.
Kim IE; Amin A; Wang LJ; Cheng L; Perrino CM
Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):687-693. PubMed ID: 31876605
[TBL] [Abstract][Full Text] [Related]
30. Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56.
Kriegsmann K; Zgorzelski C; Kazdal D; Cremer M; Muley T; Winter H; Longuespée R; Kriegsmann J; Warth A; Kriegsmann M
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):237-242. PubMed ID: 30358615
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic features and diagnostic challenges of small cluster pattern appendiceal neuroendocrine tumors.
Gertsen B; Arshi J; Li RX; Findeis-Hosey JJ; Huber AR; Hao Y
Ann Diagn Pathol; 2024 Apr; 69():152250. PubMed ID: 38142627
[TBL] [Abstract][Full Text] [Related]
32. Value of SATB2, ISL1, and TTF1 to differentiate rectal from other gastrointestinal and lung well-differentiated neuroendocrine tumors.
Zhao LH; Chen C; Mao CY; Xiao H; Fu P; Xiao HL; Wang G
Pathol Res Pract; 2019 Jul; 215(7):152448. PubMed ID: 31133441
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.
Staaf J; Tran L; Söderlund L; Nodin B; Jirström K; Vidarsdottir H; Planck M; Mattsson JSM; Botling J; Micke P; Brunnström H
Arch Pathol Lab Med; 2020 Sep; 144(9):1075-1085. PubMed ID: 31913660
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers in gastroenteropancreatic neuroendocrine neoplasms.
Jacoba IM; Weber HC
Curr Opin Endocrinol Diabetes Obes; 2023 Jun; 30(3):175-180. PubMed ID: 36895178
[TBL] [Abstract][Full Text] [Related]
35. INSM1 Is a Highly Specific Marker of Neuroendocrine Differentiation in Primary Neoplasms of the Gastrointestinal Tract, Appendix, and Pancreas.
McHugh KE; Mukhopadhyay S; Doxtader EE; Lanigan C; Allende DS
Am J Clin Pathol; 2020 May; 153(6):811-820. PubMed ID: 32128564
[TBL] [Abstract][Full Text] [Related]
36. INSM1 immunostaining in solid papillary carcinoma of the breast.
Kudo N; Takano J; Kudoh S; Arima N; Ito T
Pathol Int; 2021 Jan; 71(1):51-59. PubMed ID: 33156579
[TBL] [Abstract][Full Text] [Related]
37. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens.
Viswanathan K; Siddiqui MT; Borczuk AC
J Am Soc Cytopathol; 2019; 8(6):299-308. PubMed ID: 31345782
[TBL] [Abstract][Full Text] [Related]
38. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.
Xin Z; Zhang Y; Jiang Z; Zhao L; Fan L; Wang Y; Xie S; Shangguan X; Zhu Y; Pan J; Liu Q; Huang Y; Dong B; Xue W
Hum Pathol; 2018 Sep; 79():151-159. PubMed ID: 29885405
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical Staining With Neuroendocrine Markers is Essential in the Diagnosis of Neuroendocrine Neoplasms of the Esophagogastric Junction.
Jepsen DNM; Fiehn AK; Garbyal RS; Engel U; Holm J; Federspiel B
Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):454-461. PubMed ID: 33480601
[TBL] [Abstract][Full Text] [Related]
40. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56.
Sakakibara R; Kobayashi M; Takahashi N; Inamura K; Ninomiya H; Wakejima R; Kitazono S; Yanagitani N; Horiike A; Ichinose J; Matsuura Y; Nakao M; Mun M; Nishio M; Okumura S; Motoi N; Ito T; Miyazaki Y; Inase N; Ishikawa Y
Am J Surg Pathol; 2020 Jun; 44(6):757-764. PubMed ID: 32118626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]